Genetic variation as a guide to drug development

Science

Volumn 281, Issue 5384, 1998, Pages 1820-1821

  Kleyn, Patrick W ^a   Vesell, Elliot S ^b  

^a Millennium Predictive Medicine Inc   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; CHOLINESTERASE INHIBITOR; CYTOCHROME P450 ISOENZYME; DEXFENFLURAMINE; DIHYDROFOLATE REDUCTASE; DNA; FENFLURAMINE; FIBRINOGEN; LIPOPROTEIN LIPASE; MESSENGER RNA; MIBEFRADIL; SEROTONIN 2A RECEPTOR; TERFENADINE; THYMIDYLATE SYNTHASE;

DRUG DEVELOPMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME; HUMAN; NONHUMAN; PHARMACOGENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SHORT SURVEY;

BASE COMPOSITION; CHEMISTRY, PHARMACEUTICAL; GENETIC MARKERS; GENOTYPE; HUMANS; LINKAGE (GENETICS); MICROSATELLITE REPEATS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

EID: 0032544336     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.281.5384.1820     Document Type: Short Survey

References (20)

1. J. Drews, Nature Biotechnol. 14, 1516 (1996).
2. E. H. Corder et al., Science 261, 921 (1993).
3. J. Poirier et al., Lancet 342, 697 (1993).
4. J. Poirier et al., Proc. Natl. Acad. Sci. U.S.A. 92, 12260 (1995).
5. D. A. Nickerson et al., Nature Genet. 19, 233 (1998).
6. G. S. Zubenko et al., Genomics 50, 121 (1998).
7. M. P. M. de Maat et al., Arterioscler. Thromb. Vasc. Biol. 18, 265 (1998).
8. J. W. Jukema et al., Circulation 94, 1913 (1996).
9. J. A. Kuivenhoven et al., N. Engl. J. Med. 338, 86 (1998).
10. H. B. Muss et al., ibid. 330, 1260 (1994).
11. R. N. Van Gelder et al., Proc. Natl. Acad. Sci. U.S.A. 87, 1663 (1990).
12. M. R. Emmert-Buck et al., Science 274, 998 (1996).
13. L. Diatchecko et al., Proc. Natl. Acad. Sci. U.S.A. 93, 6025 (1996).
14. M. R. Wilkins et al., Eds., Proteome Research: New Frontiers in Functional Genomics (Springer-Verlag, New York, 1997).
15. A. Persidis, Nature Biotechnol. 16, 393 (1998).
16. K. P. Vatsis, K. J. Martell, W. W. Weber, Proc. Natl. Acad. Sci. U.S.A. 88, 6333 (1991).
17. J. R. Idle and R. L. Smith, Drug Metab. Rev. 9, 301 (1979).
18. M. J. Arrantz et al., Neurosci. Lett. 217, 177 (1996).
19. M. Kornmann et al., Cancer Lett. 118, 29 (1997).
20. J. M. Trent et al., J. Clin. Oncol. 2, 8 (1984).